Citius Pharmaceuticals, Inc. (CTXR) Financials

CTXR Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 97.4 million 12.1 million
2023-09-30 103.6 million 12.2 million
2023-06-30 110.4 million 12.1 million
2023-03-31 104.2 million 12.4 million

CTXR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -6.1 million 3.1 million
2023-09-30 -6.8 million 3.1 million
2023-06-30 -9.6 million 1.2 million
2023-03-31 -7.9 million 1.2 million

CTXR Net Income

No data available :(

CTXR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 20.3 million - 428569
2023-09-30 26.5 million - 481245
2023-06-30 33.3 million - 532882
2023-03-31 29.1 million - 582302

CTXR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 159.0 million
2023-09-30 158.9 million
2023-06-30 153.8 million
2023-03-31 146.3 million

CTXR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 2.6 million 6.7 million -
2023-09-30 - 2.9 million 7.2 million -
2023-06-30 - 3.8 million 4.9 million -
2023-03-31 - 4.7 million 6.0 million -

CTXR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 51008
2023-09-30 - 49969
2023-06-30 - 49017
2023-03-31 - 48143

CTXR

Price: $0.70

52 week price:
0.60
1.65

Earnings Per Share: -0.26 USD

P/E Ratio: -3.83

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 674400

Ebitda: -9.5 million

Market Capitalization: 121.9 million

Links: